Alira Health

Industries

Pharma

Solutions designed for growth

As your partner, Alira Health can help you navigate today’s evolving pharmaceutical industry. With an increased focus on personalized care, the current pharma landscape has a wider range of clusters, each with smaller patient pools. Your dedicated Alira Health team will work closely with you to identify the short- and long-term impacts to your goals, and create tailored solutions.
  • Research and development expenditures
  • Supply chain capacities
  • Pricing strategies

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • 360° lifecycle approach

    that supports products, technologies, and services from concept ideation to creation and commercialization

  • Regulatory

    clinical, and health expertise in medical affairs strategy and execution

  • Management consulting

    to define growth initiatives and accelerate market penetration. Learn more

  • Global transaction advisory services

    including M&A, licensing, partnering and distribution, and capital raises. Learn more

  • In-depth experience

    across the entire healthcare ecosystem—suppliers, payers, providers, and patients

  • Fully collaborative team

    of bankers, scientists, strategists, and doctors who deliver a holistic view of each project

Areas of expertise

Alira Health teams bring together top talent from every life science and healthcare sector to take your innovation from strategy to reality. Our teams specialize in:
  • Central nervous system
  • Metabolic diseases
  • Oncology
  • Rare and orphan diseases
  • Infectious diseases
  • Dermatology
  • Genetic diseases
  • Addiction diseases
  • Hematology

Local insights, global reach

Since 1999, Alira Health has increased value for its pharma, biotech, and MedTech clients around the world. Our local presence and global collaboration combined with our deep domain experience allows us to deliver actionable insights.
20+
Years serving pharma and MedTech clients
75%
Of the top 50 pharma companies are advised by Alira Health

Working together to humanize healthcare

As your industry evolves, we’re ready to help you lead the way.

Contact us
Gabriele Brambilla
Gabriele Brambilla
Chief Executive Officer
Our clients are disrupting healthcare—they are pioneering new standards of care, and we are their accelerator.

Explore our related publications:

Articles July 24, 2026
How Pharma and Medtech Convergence Is Changing DDS Partner Selection in 2026
Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.
Drug Delivery MedTech Pharma
Articles May 12, 2026
Frequently Asked Questions on the Strategic Value of Dual Branding in Pharma
Discover how dual branding in pharma enables pricing flexibility and expands access, and how to design a strategy that protects value and withstands scrutiny.
Interview Market Access Pharma
News December 8, 2025
Alira Health Advises Guala Closures on Acquisition of KWK
We are pleased to have served as commercial due diligence (CDD) advisors to Guala Closures, a global leader in specialty closure solutions, supporting its acquisition of KWK, an Austrian(...)
CDD MedTech Pharma
News October 23, 2025
Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands
Alira Health today released its 2025 Global Drug Delivery System Trends Report, highlighting the rapid evolution of the global drug delivery systems (DDS) market.
Drug Delivery Pharma
Case Studies May 30, 2025
Pharma Company Advances Fair Trials Representation With Structured Patient Engagement Strategy
A global pharmaceutical company focused on respiratory, neonatology, rare diseases, and specialty care lacked a systematic approach to enhance the recruitment and retention of diverse(...)
Patient Engagement Pharma Rare Disease
Case Studies March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy Patient Engagement Pharma
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.